Figure 2.
Comparison of annualized relapse rate before and after initiation of mycophenolate mofetil: A. patients with AQP4 seropositive NMOSD (p<0.0001), B. patients with AQP4 seronegative NMOSD (p=0.0039)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.